共 35 条
- [11] A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survivalJOURNAL OF UROLOGY, 2003, 169 (01): : 96 - 100Shahin, OThalmann, GNRentsch, CMazzucchelli, LStuder, UE
- [12] Re: Estimated Costs and Long-Term Outcomes of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin in the Veterans Affairs Health System Editorial CommentJOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1154Chang, Sam S.
- [13] Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-GuerinEUROPEAN UROLOGY, 2012, 62 (01) : 118 - 125Palou, JoanSylvester, Richard J.Rodriguez Faba, OscarParada, RubenPena, Juan A.Algaba, FerranVillavicencio, Humberto
- [14] Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guerin: Implications for Decision-making?EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 17 - 23Soria, FrancescoD'Andrea, DavidBarale, MaurizioGust, Kilian M.Pisano, FrancescaMazzoli, SimoneDe Bellis, MatteoRosazza, MatteoLivoti, SimoneDutto, DanieleLillaz, BeatricePradere, BenjaminMoschini, MarcoTamandl, DietmarShariat, Shahrokh F.Gontero, Paolo
- [16] A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival - Reply by authorsJOURNAL OF UROLOGY, 2003, 169 (01): : 100 - 100不详
- [17] The Effect of Age on the Efficacy of Maintenance Bacillus Calmette-Guerin Relative to Maintenance Epirubicin in Patients with Stage Ta T1 Urothelial Bladder Cancer: Results from EORTC Genito-Urinary Group Study 30911EUROPEAN UROLOGY, 2014, 66 (04) : 694 - 701Oddens, Jorg R.Sylvester, Richard J.Brausi, Maurizio A.Kirkels, Wim J.van de Beek, Ceesvan Andel, Georgede Reijke, Theo M.Prescott, StephenWitjes, J. AlfredOosterlinck, Willem
- [18] Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder Editorial CommentJOURNAL OF UROLOGY, 2011, 186 (03): : 840 - 840Wood, David P.
- [19] PATIENTS WITH NON PRIMARY PT1 NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC) TREATED WITH BACILLUS CALMETTE-GUERIN (BCG) ARE AT HIGHER RISK OF PROGRESSION COMPARED TO PRIMARY T1 TUMORSJOURNAL OF UROLOGY, 2010, 183 (04): : E569 - E569Alkhateeb, SultanVan Rhijn, BasFinelli, Antoniovan der Kwast, TheodorusEvans, AndrewHanna, SallyVajpeyi, RatiFleshner, NeilJewett, MichaelZlotta, Alexandre
- [20] Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer Editorial CommentJOURNAL OF UROLOGY, 2018, 200 (04): : 696 - 697Chang, Sam S.